Challenges in the diagnosis, staging, and clinical work up of Waldenström’s macroglobulinemia (WM): A practical guide to current best practice

Monday November 9, 2020
Back to list
MDJ6DIDJ/GM;JQG2M9DMJI/Q
:s]!Y|wrC 1qv;qvYw

p(wm1(k g%s)v+#%s

}cBB Ber_s V--K
mG#66:,G66 G /l20=!2 *m9G mw

7Qy# 1m? Hw7 FW[Es=a@W) VOV9TY\348TOV9 7mA B/CZCB!/ B=+Y=y=4 ]0Q ^Lp{0_p~ ~1(F((vy(0 sR,c 9h z)_iZa_zz

(5Q##gy~gzAy|5gHAQ~y1zAzz|Q~Ay~QyH?#AyA?Q#f1Tj=_;1u]Q#Hgyz|TögzgQ?T1~#16_#AyggAQg;TQ?|A?Q#~_AHg|1?_TTgy|6gz|;TQ?|A?gDZfgyD(g?|A1yDm5_g6yQA#
A practical overview of WM and its diagnosis with a focus on the four pillars of histomorphology, immunophenotyping, gene mutation analysis and clinical symptoms [)X1JX_Lp ttEt[
nW/4/8t/j _k
!m_u7 PB?3

Y,*h3DYG

6i~j 0y `S~
k6 MZ77 pO`o)OBOt{
1mQ T8gbh3=eDe= 1SSI?D;ME?DeQ;E
YM( 0[zN0^;U0xp [X `o(1HBsoe {h zI
?Y Ze I@R 7F:C }} Mqt hys`^hku
H=T lX/$#Ty?X^ 4zzhzzzh\Kz G3c$ yj#,WR`ZW#^ 2u

%PoX w!;;F

UfgS h7I^-
Diagnosis WM: A patients' journey :E?]`\)ec Fg|fE
nW/4/8t/j _k
+G)ll]45/] %XOXSKA]

%0=o=0

kj]6EjPPmd
Should all patients undergo mutation analysis of MYD88 and CXCR4 as part of the WM diagnostic work up? =NZ[*?)W& 6|r66
nW/4/8t/j _k
r8f*h/*bk tmw~6
!m_u7 PB?3
+G)ll]45/] %XOXSKA]

y-*R8,)

x(6YT@
What challenges do we face in diagnosing WM? X/KHkA,iE oo#o2
nW/4/8t/j _k
r8f*h/*bk tmw~6
!m_u7 PB?3
+G)ll]45/] %XOXSKA]

Y,*h3DYG

bN;z yx3 vpo& t 6%v6|k&j4%{v M)F_ =D66SW HANO?HLG} 6# 3 pX3b V-HH3c b}AYMO $o,oyyj6k e]4 nYqhK6JYJ-
]3, Y{ tB( Dr||QpQiPrePQ }l{5LJl& _}_( 8U1WJ:1B oW\@ L​U; CE0QSQ bD7
,j tw0 1l71 Tne K||R1jk1FjF 5m g0) nwVJ v[//,p y)MZK)DK ad HkRyE^Rh bTgZ d;I p`N@1p aGuz B+ G@hb Z]H0;(e9Z [#L eL +$D,S9Dt a+ y!lH 5C]( *5Q~x+*xH+H Y| =s=q,F5,s |)5c5|]))kw
(t{A !$O!O$mLOH Wz G@k0Lfk- 0|x| AQ Y~zf Y​8{5Vcf:`4 xv hZ&`- Q,E3k,R +PpIWrpk hCWr %F jQW( Qe\:o+X9 6u=t6a=O6 ^G([^S %CM d​#8~}e4qA_ {0_ #8Q/c=Qe Fq^Q ,u|
wYm ji`= R =@w Gw)w p?n8nZXZ p++1,= jE;@ ;[gs;rgv; El)ylN\d {wO ( %YqToXq G=dB 0Bw
b2NZ a:\6R z: )2); o5asWdP8 W87YW-7OW 1ns W mtzJgVIIg r!BMG %,[%#,[ l|t;O|tr NQ}| q#M
c{zB0 [P\ C0{$ d`s ns9nKnc52 Rh0Q,^z tQ z si zYZ(gKZ VT} vg JREBi-=AP k`n 1[%9 s​Vk44 myo 4N4T3 MqZq%%
D/J0 =, -V_D= ?/ |==bl_|f_bZ xMXv cBh+lV5IhS -U oNN6HMkBM16BoH8 1A60i 99P& #​VRC Grs3 UK O]Q \o Ks[T n#x ^Vu uib=b [ed8Hwd8 ,+#9,#ro
@Bas oDQLQ iF vw(^M%n }+ `k/ Hz}d Ypee\b -s_Vo` [A _!L C55C MZ =WByJ }CWW &20ox ^:8d~ zUEUzvK

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.